- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT05256225
Testování přidání trastuzumabu nebo trastuzumabu/pertuzumabu k obvyklé chemoterapii u HER2 pozitivního serózního karcinomu endometria nebo karcinosarkomu
Studie fáze II/III paklitaxelu/karboplatiny samostatně nebo v kombinaci s trastuzumabem a hyaluronidázou-Oysk (HERCEPTIN HYLECTA) nebo pertuzumabem, trastuzumabem a hyaluronidázou-Zzxf (PHESGO) u HER2 pozitivního karcinomu karcinosemárního karcinomu stadia I-I-
This phase III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin Hylecta [TM]) or pertuzumab, trastuzumab and hyaluronidase-zzxf (Phesgo [TM]) to the usual chemotherapy (paclitaxel and carboplatin) works to shrink tumors in patients with HER2 positive endometrial cancer. Trastuzumab and pertuzumab are monoclonal antibodies and forms of targeted therapy that attach to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When trastuzumab or pertuzumab attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Hyaluronidase is an endoglycosidase. It helps to keep pertuzumab and trastuzumab in the body longer, so that these medications will have a greater effect. Hyaluronidase also allows trastuzumab and trastuzumab/pertuzumab to be given by injection under the skin and shortens their administration time compared to trastuzumab or pertuzumab alone. Paclitaxel is a taxane and in a class of medications called antimicrotubule agents. It stops tumor cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Giving Herceptin Hylecta or Phesgo in combination with paclitaxel and carboplatin may shrink the tumor and prevent the cancer from coming back in patients with HER2 positive endometrial cancer.
Přehled studie
Postavení
Podmínky
- Karcinom endometria
- Endometriální průhledný adenokarcinom
- Endometriální dediferencovaný karcinom
- Endometrioidní endometrioidní adenokarcinom
- Endometriální smíšený buněčný adenokarcinom
- Endometriální serózní adenokarcinom
- Endometriální nediferencovaný karcinom
- Maligní smíšený mesodermální (Müllerův) tumor děložního těla
Intervence / Léčba
- Lék: Carboplatin
- Lék: Paclitaxel
- Postup: Computed Tomography
- Postup: Echocardiography Test
- Postup: Multigated Acquisition Scan
- Postup: Biospecimen Collection
- Záření: High-Dose-Rate Vaginal Cuff Brachytherapy
- Jiný: Survey Administration
- Lék: Trastuzumab/Hyaluronidase-oysk
- Lék: Hyaluronidase-zzxf/Pertuzumab/Trastuzumab
Detailní popis
PRIMARY OBJECTIVES:
I. To evaluate the efficacy of trastuzumab and hyaluronidase-oysk (HERCEPTIN HYLECTA) and pertuzumab, trastuzumab, and hyaluronidase-zzxf (PHESGO) in combination with paclitaxel/carboplatin in patients with HER2 positive endometrial cancer.
SECONDARY OBJECTIVES:
I. To evaluate the efficacy of trastuzumab and hyaluronidase-oysk (HERCEPTIN HYLECTA) and pertuzumab, trastuzumab, and hyaluronidase-zzxf (PHESGO) in combination with paclitaxel/carboplatin in patients with HER2 positive endometrial cancer.
II. To evaluate the overall response rate (ORR) in patients with measurable disease.
III. To evaluate the duration of objective response in patients with measurable disease as assessed by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1.
IV. To determine the nature, frequency and degree of toxicity as assessed by Common Terminology Criteria for Adverse Events (CTCAE) version (v.) 5.0 for each treatment arm.
V. To compare quality of life (QOL), as measured by Functional Assessment of Cancer Therapy - Endometrial Trial Outcome Index (FACT-En-TOI), in the experimental versus control arms.
VI. To compare patient-reported treatment-associated symptoms (diarrhea and rash) as measured with the Patient Reported Outcomes (PRO) - CTCAE, patient-reported fatigue as measured with the Patient Reported Outcomes Measurement Information System (PROMIS)-Fatigue short form, and worry concerning side effects of treatment as measured by the item 'bothered by side effect', in the FACT-En TOI, respectively, in the experimental and control arms.
VII. To assess the correlation of HER2 immunohistochemistry (IHC) expression and in situ hybridization (ISH) amplification with clinical outcome and response to HER2 targeted therapies.
EXPLORATORY OBJECTIVE:
I. To explore time to sustained deterioration in quality of life, as measured by a drop in the FACT-En-TOI by 6 or more points lasting for more than one PRO time point, in the experimental and control arms.
OUTLINE: Patients are randomized to 1 of 3 arms.
ARM I: Patients receive paclitaxel intravenously (IV) over 3 hours and carboplatin IV over 30-60 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for 6 cycles in the absence of disease progression or unacceptable toxicity. Patients with stable disease (SD) or partial response (PR) who still have measurable disease after completion of cycle 6 may receive 4 additional cycles of this treatment at the discretion of the treating physician.
ARM II: Patients receive paclitaxel IV over 3 hours, carboplatin IV over 30-60 minutes, and trastuzumab/hyaluronidase-oysk subcutaneously (SC) over 2-5 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for 6 cycles in the absence of disease progression or unacceptable toxicity. Patients with SD or PR who still have measurable disease after completion of cycle 6 may receive 4 additional cycles of this treatment at the discretion of the treating physician.
MAINTENANCE: Patients receive trastuzumab/hyaluronidase-oysk SC over 2-5 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for up to 1 year in the absence of disease progression or unacceptable toxicity. Patients with SD or PR may continue maintenance therapy for up to 3 years from the start of treatment.
ARM III: Patients receive paclitaxel IV over 3 hours, carboplatin IV over 30-60 minutes, and pertuzumab/trastuzumab/hyaluronidase-zzxf SC over 5-8 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for 6 cycles in the absence of disease progression or unacceptable toxicity. Patients with SD or PR who still have measurable disease after completion of cycle 6 may receive 4 additional cycles of this treatment at the discretion of the treating physician.
MAINTENANCE: Patients receive pertuzumab/trastuzumab/ hyaluronidase-zzxf SC over 5 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for up to 1 year in absence of disease progression or unacceptable toxicity. Patients with SD or PR may continue maintenance for up to 3 years from the start of treatment.
Patients undergo echocardiography (ECHO) or multigated acquisition scan (MUGA) and computed tomography (CT) throughout the study. Additionally, patients may optionally undergo blood sample collection throughout the study, vaginal brachytherapy on study, and urine sample collection prior to treatment.
After completion of study treatment, patients are followed up every 3 months for 2 years and then every 6 months for 3 years.
Typ studie
Zápis (Odhadovaný)
Fáze
- Fáze 3
Kontakty a umístění
Studijní místa
-
-
-
Seoul, Jižní Korea, 06273
- Gangnam Severance Hospital
-
-
Daegu
-
Dalseo-gu, Daegu, Jižní Korea, 42601
- Keimyung University-Dongsan Medical Center
-
-
Gyeongsangnam-do
-
Seoul, Gyeongsangnam-do, Jižní Korea, 51353
- Samsung Changwon Hospital
-
-
Kyeonggi-do
-
Seongnam, Kyeonggi-do, Jižní Korea, 463-707
- Seoul National University Bundang Hospital
-
-
-
-
-
San Juan, Portoriko, 00927
- Centro Comprensivo de Cancer de UPR
-
-
-
-
Alabama
-
Birmingham, Alabama, Spojené státy, 35233
- University of Alabama at Birmingham Cancer Center
-
-
Alaska
-
Anchorage, Alaska, Spojené státy, 99508
- Alaska Women's Cancer Care
-
-
Arizona
-
Tucson, Arizona, Spojené státy, 85719
- Banner University Medical Center - Tucson
-
Tucson, Arizona, Spojené státy, 85719
- University of Arizona Cancer Center-North Campus
-
-
Arkansas
-
Little Rock, Arkansas, Spojené státy, 72205
- University of Arkansas for Medical Sciences
-
-
California
-
Auburn, California, Spojené státy, 95602
- Sutter Auburn Faith Hospital
-
Berkeley, California, Spojené státy, 94704
- Alta Bates Summit Medical Center-Herrick Campus
-
Concord, California, Spojené státy, 94520
- John Muir Medical Center-Concord
-
Duarte, California, Spojené státy, 91010
- City of Hope Comprehensive Cancer Center
-
Huntington Beach, California, Spojené státy, 92648
- City of Hope Seacliff
-
Irvine, California, Spojené státy, 92618
- Kaiser Permanente-Irvine
-
Irvine, California, Spojené státy, 92618
- City of Hope at Irvine Lennar
-
Irvine, California, Spojené státy, 92612
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
-
Long Beach, California, Spojené státy, 90813
- City of Hope at Long Beach Elm
-
Los Angeles, California, Spojené státy, 90027
- Kaiser Permanente Los Angeles Medical Center
-
Modesto, California, Spojené státy, 95355
- Memorial Medical Center
-
Mountain View, California, Spojené státy, 94040
- Palo Alto Medical Foundation-Gynecologic Oncology
-
Orange, California, Spojené státy, 92868
- UC Irvine Health/Chao Family Comprehensive Cancer Center
-
Orange, California, Spojené státy, 92868
- Saint Joseph Hospital - Orange
-
Palo Alto, California, Spojené státy, 94304
- Stanford Cancer Institute Palo Alto
-
Panorama City, California, Spojené státy, 91402
- Kaiser Permanente - Panorama City
-
Riverside, California, Spojené státy, 92505
- Kaiser Permanente-Riverside
-
Roseville, California, Spojené státy, 95661
- Sutter Roseville Medical Center
-
Sacramento, California, Spojené státy, 95816
- Sutter Medical Center Sacramento
-
Sacramento, California, Spojené státy, 95817
- University of California Davis Comprehensive Cancer Center
-
San Francisco, California, Spojené státy, 94115
- California Pacific Medical Center-Pacific Campus
-
Santa Cruz, California, Spojené státy, 95065
- Palo Alto Medical Foundation-Santa Cruz
-
Sunnyvale, California, Spojené státy, 94086
- Palo Alto Medical Foundation-Sunnyvale
-
Upland, California, Spojené státy, 91786
- City of Hope Upland
-
Walnut Creek, California, Spojené státy, 94598
- John Muir Medical Center-Walnut Creek
-
-
Colorado
-
Aurora, Colorado, Spojené státy, 80045
- UCHealth University of Colorado Hospital
-
Denver, Colorado, Spojené státy, 80206
- UCHealth - Cherry Creek
-
Denver, Colorado, Spojené státy, 80210
- AdventHealth Porter
-
Grand Junction, Colorado, Spojené státy, 81505
- Grand Valley Oncology
-
Greeley, Colorado, Spojené státy, 80631
- Banner North Colorado Medical Center
-
Highlands Ranch, Colorado, Spojené státy, 80129
- UCHealth Highlands Ranch Hospital
-
Loveland, Colorado, Spojené státy, 80539
- Banner North Colorado Medical Center - Loveland Campus
-
-
Connecticut
-
Danbury, Connecticut, Spojené státy, 06810
- Danbury Hospital
-
Derby, Connecticut, Spojené státy, 06418
- Smilow Cancer Hospital-Derby Care Center
-
Fairfield, Connecticut, Spojené státy, 06824
- Smilow Cancer Hospital Care Center-Fairfield
-
Glastonbury, Connecticut, Spojené státy, 06033
- Smilow Cancer Hospital Care Center at Glastonbury
-
Greenwich, Connecticut, Spojené státy, 06830
- Smilow Cancer Hospital Care Center at Greenwich
-
Guilford, Connecticut, Spojené státy, 06437
- Smilow Cancer Hospital Care Center - Guilford
-
Hartford, Connecticut, Spojené státy, 06105
- Smilow Cancer Hospital Care Center at Saint Francis
-
New Haven, Connecticut, Spojené státy, 06520
- Yale University
-
North Haven, Connecticut, Spojené státy, 06473
- Yale-New Haven Hospital North Haven Medical Center
-
Norwalk, Connecticut, Spojené státy, 06856
- Norwalk Hospital
-
Stamford, Connecticut, Spojené státy, 06902
- Smilow Cancer Hospital Care Center at Long Ridge
-
Torrington, Connecticut, Spojené státy, 06790
- Smilow Cancer Hospital-Torrington Care Center
-
Trumbull, Connecticut, Spojené státy, 06611
- Smilow Cancer Hospital Care Center-Trumbull
-
Waterbury, Connecticut, Spojené státy, 06708
- Smilow Cancer Hospital-Waterbury Care Center
-
Waterford, Connecticut, Spojené státy, 06385
- Smilow Cancer Hospital Care Center - Waterford
-
-
Delaware
-
Newark, Delaware, Spojené státy, 19713
- Helen F Graham Cancer Center
-
Newark, Delaware, Spojené státy, 19713
- Medical Oncology Hematology Consultants PA
-
-
District of Columbia
-
Washington D.C., District of Columbia, Spojené státy, 20037
- George Washington University Medical Center
-
Washington D.C., District of Columbia, Spojené státy, 20016
- Sibley Memorial Hospital
-
-
Florida
-
Fort Lauderdale, Florida, Spojené státy, 33316
- Broward Health Medical Center
-
Jupiter, Florida, Spojené státy, 33458
- Jupiter Medical Center
-
N. Venice, Florida, Spojené státy, 34275
- Sarasota Memorial Hospital-Venice
-
Orlando, Florida, Spojené státy, 32803
- AdventHealth Orlando
-
Sarasota, Florida, Spojené státy, 34239
- Sarasota Memorial Hospital
-
Sarasota, Florida, Spojené státy, 34239
- Florida Cancer Specialists - Sarasota Downtown
-
Sarasota, Florida, Spojené státy, 34239
- FPG - Surgical Oncology Clinics Gynecologic Oncology Surgery
-
Venice, Florida, Spojené státy, 34275
- Florida Cancer Specialists - Venice Pinebrook
-
-
Georgia
-
Atlanta, Georgia, Spojené státy, 30308
- Emory University Hospital Midtown
-
Atlanta, Georgia, Spojené státy, 30322
- Emory University Hospital/Winship Cancer Institute
-
Atlanta, Georgia, Spojené státy, 30342
- Emory Saint Joseph's Hospital
-
Atlanta, Georgia, Spojené státy, 30303
- Grady Health System
-
Atlanta, Georgia, Spojené státy, 30309
- Piedmont Hospital
-
Augusta, Georgia, Spojené státy, 30912
- Augusta University Medical Center
-
Decatur, Georgia, Spojené státy, 30033
- Emory Decatur Hospital
-
Savannah, Georgia, Spojené státy, 31405
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
-
-
Hawaii
-
Honolulu, Hawaii, Spojené státy, 96813
- Queen's Medical Center
-
Honolulu, Hawaii, Spojené státy, 96826
- Kapiolani Medical Center for Women and Children
-
-
Idaho
-
Boise, Idaho, Spojené státy, 83706
- Saint Alphonsus Cancer Care Center-Boise
-
Boise, Idaho, Spojené státy, 83712
- Saint Luke's Cancer Institute - Boise
-
Caldwell, Idaho, Spojené státy, 83605
- Saint Alphonsus Cancer Care Center-Caldwell
-
Coeur d'Alene, Idaho, Spojené státy, 83814
- Kootenai Health - Coeur d'Alene
-
Fruitland, Idaho, Spojené státy, 83619
- Saint Luke's Cancer Institute - Fruitland
-
Meridian, Idaho, Spojené státy, 83642
- Saint Luke's Cancer Institute - Meridian
-
Nampa, Idaho, Spojené státy, 83687
- Saint Alphonsus Cancer Care Center-Nampa
-
Nampa, Idaho, Spojené státy, 83687
- Saint Luke's Cancer Institute - Nampa
-
Post Falls, Idaho, Spojené státy, 83854
- Kootenai Clinic Cancer Services - Post Falls
-
Sandpoint, Idaho, Spojené státy, 83864
- Kootenai Clinic Cancer Services - Sandpoint
-
Twin Falls, Idaho, Spojené státy, 83301
- Saint Luke's Cancer Institute - Twin Falls
-
-
Illinois
-
Arlington Heights, Illinois, Spojené státy, 60005
- Northwest Community Hospital
-
Aurora, Illinois, Spojené státy, 60504
- Rush-Copley Medical Center
-
Centralia, Illinois, Spojené státy, 62801
- Centralia Oncology Clinic
-
Chicago, Illinois, Spojené státy, 60611
- Northwestern University
-
Chicago, Illinois, Spojené státy, 60637
- University of Chicago Comprehensive Cancer Center
-
Chicago, Illinois, Spojené státy, 60612
- John H Stroger Jr Hospital of Cook County
-
Chicago, Illinois, Spojené státy, 60612
- Rush MD Anderson Cancer Center
-
Danville, Illinois, Spojené státy, 61832
- Carle at The Riverfront
-
DeKalb, Illinois, Spojené státy, 60115
- Northwestern Medicine Cancer Center Kishwaukee
-
Decatur, Illinois, Spojené státy, 62526
- Decatur Memorial Hospital
-
Decatur, Illinois, Spojené státy, 62526
- Cancer Care Specialists of Illinois - Decatur
-
Effingham, Illinois, Spojené státy, 62401
- Crossroads Cancer Center
-
Effingham, Illinois, Spojené státy, 62401
- Carle Physician Group-Effingham
-
Evanston, Illinois, Spojené státy, 60201
- NorthShore University HealthSystem-Evanston Hospital
-
Geneva, Illinois, Spojené státy, 60134
- Northwestern Medicine Cancer Center Delnor
-
Glenview, Illinois, Spojené státy, 60026
- NorthShore University HealthSystem-Glenbrook Hospital
-
Glenview, Illinois, Spojené státy, 60026
- Northwestern Medicine Glenview Outpatient Center
-
Grayslake, Illinois, Spojené státy, 60030
- Northwestern Medicine Grayslake Outpatient Center
-
Harvey, Illinois, Spojené státy, 60426
- Ingalls Memorial Hospital
-
Highland Park, Illinois, Spojené státy, 60035
- NorthShore University HealthSystem-Highland Park Hospital
-
Hinsdale, Illinois, Spojené státy, 60521
- Sudarshan K Sharma MD Limited-Gynecologic Oncology
-
Lake Forest, Illinois, Spojené státy, 60045
- Northwestern Medicine Lake Forest Hospital
-
Mattoon, Illinois, Spojené státy, 61938
- Carle Physician Group-Mattoon/Charleston
-
New Lenox, Illinois, Spojené státy, 60451
- UC Comprehensive Cancer Center at Silver Cross
-
Normal, Illinois, Spojené státy, 61761
- Carle Cancer Institute Normal
-
O'Fallon, Illinois, Spojené státy, 62269
- Cancer Care Center of O'Fallon
-
Orland Park, Illinois, Spojené státy, 60462
- University of Chicago Medicine-Orland Park
-
Orland Park, Illinois, Spojené státy, 60462
- Northwestern Medicine Orland Park
-
Rockford, Illinois, Spojené státy, 61114
- UW Health Carbone Cancer Center Rockford
-
Springfield, Illinois, Spojené státy, 62702
- Southern Illinois University School of Medicine
-
Springfield, Illinois, Spojené státy, 62702
- Springfield Clinic
-
Springfield, Illinois, Spojené státy, 62781
- Springfield Memorial Hospital
-
Urbana, Illinois, Spojené státy, 61801
- Carle Cancer Center
-
Warrenville, Illinois, Spojené státy, 60555
- Northwestern Medicine Cancer Center Warrenville
-
Yorkville, Illinois, Spojené státy, 60560
- Rush-Copley Healthcare Center
-
-
Indiana
-
Carmel, Indiana, Spojené státy, 46032
- IU Health North Hospital
-
Crown Point, Indiana, Spojené státy, 46307
- UChicago Medicine Northwest Indiana
-
Crown Point, Indiana, Spojené státy, 46307
- Northwest Cancer Center - Crown Point
-
Dyer, Indiana, Spojené státy, 46311
- Northwest Oncology LLC
-
Goshen, Indiana, Spojené státy, 46526
- Goshen Center for Cancer Care
-
Hobart, Indiana, Spojené státy, 46342
- Northwest Cancer Center - Hobart
-
Hobart, Indiana, Spojené státy, 46342
- Saint Mary Medical Center
-
Indianapolis, Indiana, Spojené státy, 46237
- Franciscan Health Indianapolis
-
Indianapolis, Indiana, Spojené státy, 46202
- Indiana University/Melvin and Bren Simon Cancer Center
-
Indianapolis, Indiana, Spojené státy, 46260
- Ascension Saint Vincent Indianapolis Hospital
-
Indianapolis, Indiana, Spojené státy, 46312
- Saint Catherine Hospital
-
Lafayette, Indiana, Spojené státy, 47905
- Franciscan Saint Elizabeth Health - Lafayette East
-
Mooresville, Indiana, Spojené státy, 46158
- Franciscan Health Mooresville
-
Munster, Indiana, Spojené státy, 46321
- The Community Hospital
-
Munster, Indiana, Spojené státy, 46321
- Women's Diagnostic Center - Munster
-
South Bend, Indiana, Spojené státy, 46601
- Memorial Hospital of South Bend
-
Valparaiso, Indiana, Spojené státy, 46383
- Northwest Cancer Center - Valparaiso
-
-
Iowa
-
Ames, Iowa, Spojené státy, 50010
- Mary Greeley Medical Center
-
Ames, Iowa, Spojené státy, 50010
- McFarland Clinic - Ames
-
Boone, Iowa, Spojené státy, 50036
- McFarland Clinic - Boone
-
Council Bluffs, Iowa, Spojené státy, 51503
- Heartland Oncology and Hematology LLP
-
Council Bluffs, Iowa, Spojené státy, 51503
- Nebraska Cancer Specialists/Oncology Hematology West PC - MEJ
-
Fort Dodge, Iowa, Spojené státy, 50501
- McFarland Clinic - Trinity Cancer Center
-
Iowa City, Iowa, Spojené státy, 52242
- University of Iowa/Holden Comprehensive Cancer Center
-
Jefferson, Iowa, Spojené státy, 50129
- McFarland Clinic - Jefferson
-
Marshalltown, Iowa, Spojené státy, 50158
- McFarland Clinic - Marshalltown
-
-
Kansas
-
Shawnee Mission, Kansas, Spojené státy, 66204
- AdventHealth Shawnee Mission
-
-
Kentucky
-
Edgewood, Kentucky, Spojené státy, 41017
- Saint Elizabeth Healthcare Edgewood
-
Lexington, Kentucky, Spojené státy, 40503
- Baptist Health Lexington
-
Louisville, Kentucky, Spojené státy, 40207
- Baptist Health Louisville
-
-
Louisiana
-
Baton Rouge, Louisiana, Spojené státy, 70805
- LSU Health Baton Rouge-North Clinic
-
Baton Rouge, Louisiana, Spojené státy, 70817
- Our Lady of the Lake Medical Oncology
-
Baton Rouge, Louisiana, Spojené státy, 70808
- Our Lady of the Lake Physician Group
-
Covington, Louisiana, Spojené státy, 70433
- Ochsner Hematology Oncology North Shore - Covington (West Region)
-
Marrero, Louisiana, Spojené státy, 70072
- West Jefferson Medical Center
-
Metairie, Louisiana, Spojené státy, 70006
- East Jefferson General Hospital
-
Metairie, Louisiana, Spojené státy, 70006
- LSU Healthcare Network / Metairie Multi-Specialty Clinic
-
New Orleans, Louisiana, Spojené státy, 70121
- Ochsner Medical Center Jefferson
-
New Orleans, Louisiana, Spojené státy, 70112
- University Medical Center New Orleans
-
New Orleans, Louisiana, Spojené státy, 70115
- Ochsner Baptist Medical Center
-
-
Maine
-
Augusta, Maine, Spojené státy, 04330
- Harold Alfond Center for Cancer Care
-
Scarborough, Maine, Spojené státy, 04074
- MaineHealth Maine Medical Center- Scarborough
-
-
Maryland
-
Baltimore, Maryland, Spojené státy, 21237
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute
-
Baltimore, Maryland, Spojené státy, 21287
- Johns Hopkins University/Sidney Kimmel Cancer Center
-
Baltimore, Maryland, Spojené státy, 21215
- Sinai Hospital of Baltimore
-
Baltimore, Maryland, Spojené státy, 21204
- Greater Baltimore Medical Center
-
Bethesda, Maryland, Spojené státy, 20889-5600
- Walter Reed National Military Medical Center
-
Westminster, Maryland, Spojené státy, 21157
- William E Kahlert Regional Cancer Center/Sinai Hospital
-
-
Massachusetts
-
Springfield, Massachusetts, Spojené státy, 01199
- Baystate Medical Center
-
-
Michigan
-
Ann Arbor, Michigan, Spojené státy, 48109
- University of Michigan Rogel Cancer Center
-
Battle Creek, Michigan, Spojené státy, 49017
- Bronson Battle Creek
-
Brighton, Michigan, Spojené státy, 48114
- Trinity Health IHA Medical Group Hematology Oncology - Brighton
-
Canton, Michigan, Spojené státy, 48188
- Trinity Health IHA Medical Group Hematology Oncology - Canton
-
Chelsea, Michigan, Spojené státy, 48118
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
-
Detroit, Michigan, Spojené státy, 48201
- Wayne State University/Karmanos Cancer Institute
-
Farmington Hills, Michigan, Spojené státy, 48334
- Weisberg Cancer Treatment Center
-
Farmington Hills, Michigan, Spojené státy, 48336
- Corewell Health Farmington Hills Hospital
-
Flint, Michigan, Spojené státy, 48503
- Hurley Medical Center
-
Flint, Michigan, Spojené státy, 48503
- Genesee Hematology Oncology PC
-
Flint, Michigan, Spojené státy, 48503
- Genesys Hurley Cancer Institute
-
Flint, Michigan, Spojené státy, 48503
- Cancer Hematology Centers - Flint
-
Grand Rapids, Michigan, Spojené státy, 49503
- Trinity Health Grand Rapids Hospital
-
Grand Rapids, Michigan, Spojené státy, 49503
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
-
Kalamazoo, Michigan, Spojené státy, 49007
- West Michigan Cancer Center
-
Kalamazoo, Michigan, Spojené státy, 49007
- Bronson Methodist Hospital
-
Kalamazoo, Michigan, Spojené státy, 49009
- Beacon Kalamazoo Cancer Center
-
Lansing, Michigan, Spojené státy, 48912
- University of Michigan Health - Sparrow Lansing
-
Livonia, Michigan, Spojené státy, 48154
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Muskegon, Michigan, Spojené státy, 49444
- Trinity Health Muskegon Hospital
-
Niles, Michigan, Spojené státy, 49120
- Corewell Health Lakeland Hospitals - Niles Hospital
-
Norton Shores, Michigan, Spojené státy, 49444
- Cancer and Hematology Centers of Western Michigan - Norton Shores
-
Pontiac, Michigan, Spojené státy, 48341
- Trinity Health Saint Joseph Mercy Oakland Hospital
-
Reed City, Michigan, Spojené státy, 49677
- Corewell Health Reed City Hospital
-
Royal Oak, Michigan, Spojené státy, 48073
- Corewell Health William Beaumont University Hospital
-
Saginaw, Michigan, Spojené státy, 48604
- Oncology Hematology Associates of Saginaw Valley PC
-
Saginaw, Michigan, Spojené státy, 48601
- MyMichigan Medical Center Saginaw
-
Saint Joseph, Michigan, Spojené státy, 49085
- Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
-
Saint Joseph, Michigan, Spojené státy, 49085
- Corewell Health Lakeland Hospitals - Saint Joseph Hospital
-
Tawas City, Michigan, Spojené státy, 48764
- MyMichigan Medical Center Tawas
-
Traverse City, Michigan, Spojené státy, 49684
- Munson Medical Center
-
Troy, Michigan, Spojené státy, 48085
- Corewell Health Beaumont Troy Hospital
-
West Branch, Michigan, Spojené státy, 48661
- Saint Mary's Oncology/Hematology Associates of West Branch
-
Wyoming, Michigan, Spojené státy, 49519
- University of Michigan Health - West
-
Ypsilanti, Michigan, Spojené státy, 48197
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
-
-
Minnesota
-
Coon Rapids, Minnesota, Spojené státy, 55433
- Mercy Hospital
-
Edina, Minnesota, Spojené státy, 55435
- Fairview Southdale Hospital
-
Edina, Minnesota, Spojené státy, 55435
- Minnesota Oncology - Edina
-
Maplewood, Minnesota, Spojené státy, 55109
- Minnesota Oncology Hematology PA-Maplewood
-
Marshall, Minnesota, Spojené státy, 56258
- Avera Cancer Institute at Marshall
-
Minneapolis, Minnesota, Spojené státy, 55407
- Abbott-Northwestern Hospital
-
Minneapolis, Minnesota, Spojené státy, 55455
- University of Minnesota/Masonic Cancer Center
-
Saint Louis Park, Minnesota, Spojené státy, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Paul, Minnesota, Spojené státy, 55101
- Regions Hospital
-
Saint Paul, Minnesota, Spojené státy, 55102
- United Hospital
-
Woodbury, Minnesota, Spojené státy, 55125
- Minnesota Oncology Hematology PA-Woodbury
-
-
Missouri
-
Columbia, Missouri, Spojené státy, 65212
- MU Health - University Hospital/Ellis Fischel Cancer Center
-
Rolla, Missouri, Spojené státy, 65401
- Phelps Health Delbert Day Cancer Institute
-
Springfield, Missouri, Spojené státy, 65807
- CoxHealth South Hospital
-
St Louis, Missouri, Spojené státy, 63110
- Washington University School of Medicine
-
St Louis, Missouri, Spojené státy, 63141
- Mercy Hospital Saint Louis
-
St Louis, Missouri, Spojené státy, 63128
- Mercy Hospital South
-
-
Montana
-
Anaconda, Montana, Spojené státy, 59711
- Community Hospital of Anaconda
-
Billings, Montana, Spojené státy, 59101
- Billings Clinic Cancer Center
-
Billings, Montana, Spojené státy, 59102
- Saint Vincent Frontier Cancer Center
-
Billings, Montana, Spojené státy, 59106
- Intermountain Health West End Clinic
-
Bozeman, Montana, Spojené státy, 59715
- Bozeman Health Deaconess Hospital
-
Great Falls, Montana, Spojené státy, 59405
- Benefis Sletten Cancer Institute
-
Kalispell, Montana, Spojené státy, 59901
- Logan Health Medical Center
-
Missoula, Montana, Spojené státy, 59802
- Saint Patrick Hospital - Community Hospital
-
Missoula, Montana, Spojené státy, 59804
- Community Medical Center
-
-
Nebraska
-
Omaha, Nebraska, Spojené státy, 68114
- Nebraska Methodist Hospital
-
Omaha, Nebraska, Spojené státy, 68198
- University of Nebraska Medical Center
-
Omaha, Nebraska, Spojené státy, 68124
- Alegent Health Bergan Mercy Medical Center
-
Omaha, Nebraska, Spojené státy, 68114
- Nebraska Cancer Specialists/Oncology Hematology West PC - MECC
-
-
Nevada
-
Las Vegas, Nevada, Spojené státy, 89102
- OptumCare Cancer Care at Charleston
-
Las Vegas, Nevada, Spojené státy, 89106
- Women's Cancer Center of Nevada
-
Las Vegas, Nevada, Spojené státy, 89183
- OptumCare Cancer Care at Fort Apache
-
-
New Jersey
-
Basking Ridge, New Jersey, Spojené státy, 07920
- Memorial Sloan Kettering Basking Ridge
-
Camden, New Jersey, Spojené státy, 08103
- Cooper Hospital University Medical Center
-
Hackensack, New Jersey, Spojené státy, 07601
- Hackensack University Medical Center
-
Lakewood, New Jersey, Spojené státy, 08701
- Monmouth Medical Center Southern Campus
-
Livingston, New Jersey, Spojené státy, 07039
- Cooperman Barnabas Medical Center
-
Long Branch, New Jersey, Spojené státy, 07740
- Monmouth Medical Center
-
Middletown, New Jersey, Spojené státy, 07748
- Memorial Sloan Kettering Monmouth
-
Montvale, New Jersey, Spojené státy, 07645
- Memorial Sloan Kettering Bergen
-
Moorestown, New Jersey, Spojené státy, 08057
- Virtua Samson Cancer Center
-
Neptune City, New Jersey, Spojené státy, 07753
- Jersey Shore Medical Center
-
New Brunswick, New Jersey, Spojené státy, 08903
- Rutgers Cancer Institute of New Jersey
-
Newark, New Jersey, Spojené státy, 07101
- Rutgers New Jersey Medical School
-
Red Bank, New Jersey, Spojené státy, 07701
- Riverview Medical Center/Booker Cancer Center
-
Sewell, New Jersey, Spojené státy, 08080
- Sidney Kimmel Cancer Center Washington Township
-
Somerville, New Jersey, Spojené státy, 08876
- Robert Wood Johnson University Hospital Somerset
-
Toms River, New Jersey, Spojené státy, 08755
- Community Medical Center
-
Voorhees Township, New Jersey, Spojené státy, 08043
- Virtua Voorhees
-
-
New Mexico
-
Albuquerque, New Mexico, Spojené státy, 87106
- University of New Mexico Cancer Center
-
Albuquerque, New Mexico, Spojené státy, 87110
- Presbyterian Kaseman Hospital
-
Rio Rancho, New Mexico, Spojené státy, 87124
- Presbyterian Rust Medical Center/Jorgensen Cancer Center
-
-
New York
-
Albany, New York, Spojené státy, 12208
- Women's Cancer Care Associates LLC
-
Commack, New York, Spojené státy, 11725
- Memorial Sloan Kettering Commack
-
Harrison, New York, Spojené státy, 10604
- Memorial Sloan Kettering Westchester
-
Mineola, New York, Spojené státy, 11501
- NYU Langone Hospital - Long Island
-
New York, New York, Spojené státy, 10065
- Memorial Sloan Kettering Cancer Center
-
New York, New York, Spojené státy, 10029
- Mount Sinai Hospital
-
New York, New York, Spojené státy, 10011
- Mount Sinai Chelsea
-
New York, New York, Spojené státy, 10016
- Laura and Isaac Perlmutter Cancer Center at NYU Langone
-
Rochester, New York, Spojené státy, 14642
- University of Rochester
-
Syracuse, New York, Spojené státy, 13210
- State University of New York Upstate Medical University
-
The Bronx, New York, Spojené státy, 10461
- Montefiore Medical Center-Einstein Campus
-
The Bronx, New York, Spojené státy, 10467
- Montefiore Medical Center - Moses Campus
-
The Bronx, New York, Spojené státy, 10461
- Montefiore Medical Center-Weiler Hospital
-
Uniondale, New York, Spojené státy, 11553
- Memorial Sloan Kettering Nassau
-
Webster, New York, Spojené státy, 14580
- Wilmot Cancer Institute at Webster
-
-
North Carolina
-
Cary, North Carolina, Spojené státy, 27518
- Duke Cancer Center Cary
-
Chapel Hill, North Carolina, Spojené státy, 27599
- UNC Lineberger Comprehensive Cancer Center
-
Durham, North Carolina, Spojené státy, 27710
- Duke University Medical Center
-
Greenville, North Carolina, Spojené státy, 27834
- ECU Health Medical Center
-
High Point, North Carolina, Spojené státy, 27262
- Hayworth Cancer Center
-
Raleigh, North Carolina, Spojené státy, 27607
- Duke Women's Cancer Care Raleigh
-
Wilmington, North Carolina, Spojené státy, 28401
- Novant Health New Hanover Regional Medical Center
-
Winston-Salem, North Carolina, Spojené státy, 27157
- Wake Forest University Health Sciences
-
-
North Dakota
-
Bismarck, North Dakota, Spojené státy, 58501
- Sanford Bismarck Medical Center
-
Fargo, North Dakota, Spojené státy, 58122
- Sanford Roger Maris Cancer Center
-
Fargo, North Dakota, Spojené státy, 58122
- Sanford Broadway Medical Center
-
-
Ohio
-
Beachwood, Ohio, Spojené státy, 44122
- UHHS-Chagrin Highlands Medical Center
-
Belpre, Ohio, Spojené státy, 45714
- Strecker Cancer Center-Belpre
-
Canton, Ohio, Spojené státy, 44710
- Aultman Health Foundation
-
Centerville, Ohio, Spojené státy, 45459
- Miami Valley Hospital South
-
Chardon, Ohio, Spojené státy, 44024
- Geauga Hospital
-
Chillicothe, Ohio, Spojené státy, 45601
- Adena Regional Medical Center
-
Cincinnati, Ohio, Spojené státy, 45220
- Good Samaritan Hospital - Cincinnati
-
Cleveland, Ohio, Spojené státy, 44106
- Case Western Reserve University
-
Cleveland, Ohio, Spojené státy, 44109
- MetroHealth Medical Center
-
Columbus, Ohio, Spojené státy, 43214
- Riverside Methodist Hospital
-
Columbus, Ohio, Spojené státy, 43210
- Ohio State University Comprehensive Cancer Center
-
Columbus, Ohio, Spojené státy, 43219
- The Mark H Zangmeister Center
-
Columbus, Ohio, Spojené státy, 43213
- Mount Carmel East Hospital
-
Dayton, Ohio, Spojené státy, 45409
- Miami Valley Hospital
-
Dayton, Ohio, Spojené státy, 45415
- Miami Valley Hospital North
-
Franklin, Ohio, Spojené státy, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Greenville, Ohio, Spojené státy, 45331
- Miami Valley Cancer Care and Infusion
-
Grove City, Ohio, Spojené státy, 43123
- Mount Carmel Grove City Hospital
-
Lancaster, Ohio, Spojené státy, 43130
- Fairfield Medical Center
-
Lima, Ohio, Spojené státy, 45801
- Saint Rita's Medical Center
-
Marietta, Ohio, Spojené státy, 45750
- Marietta Memorial Hospital
-
Marysville, Ohio, Spojené státy, 43040
- Memorial Hospital
-
Mentor, Ohio, Spojené státy, 44060
- UH Seidman Cancer Center at Lake Health Mentor Campus
-
Mount Vernon, Ohio, Spojené státy, 43050
- Knox Community Hospital
-
Newark, Ohio, Spojené státy, 43055
- Licking Memorial Hospital
-
Parma, Ohio, Spojené státy, 44129
- University Hospitals Parma Medical Center
-
Perrysburg, Ohio, Spojené státy, 43551
- Mercy Health - Perrysburg Hospital
-
Portsmouth, Ohio, Spojené státy, 45662
- Southern Ohio Medical Center
-
Springfield, Ohio, Spojené státy, 45504
- Springfield Regional Cancer Center
-
Springfield, Ohio, Spojené státy, 45504
- Springfield Regional Medical Center
-
Sylvania, Ohio, Spojené státy, 43560
- ProMedica Flower Hospital
-
Toledo, Ohio, Spojené státy, 43623
- Mercy Health - Saint Anne Hospital
-
Toledo, Ohio, Spojené státy, 43608
- Mercy Health - Saint Vincent Hospital
-
Troy, Ohio, Spojené státy, 45373
- Upper Valley Medical Center
-
Westerville, Ohio, Spojené státy, 43081
- Saint Ann's Hospital
-
Westlake, Ohio, Spojené státy, 44145
- UH Seidman Cancer Center at Saint John Medical Center
-
Zanesville, Ohio, Spojené státy, 43701
- Genesis Healthcare System Cancer Care Center
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Spojené státy, 73104
- University of Oklahoma Health Sciences Center
-
Oklahoma City, Oklahoma, Spojené státy, 73120
- Mercy Hospital Oklahoma City
-
Tulsa, Oklahoma, Spojené státy, 74146
- Oklahoma Cancer Specialists and Research Institute-Tulsa
-
-
Oregon
-
Clackamas, Oregon, Spojené státy, 97015
- Providence Cancer Institute Clackamas Clinic
-
Newberg, Oregon, Spojené státy, 97132
- Providence Newberg Medical Center
-
Ontario, Oregon, Spojené státy, 97914
- Saint Alphonsus Cancer Care Center-Ontario
-
Portland, Oregon, Spojené státy, 97239
- Oregon Health and Science University
-
Portland, Oregon, Spojené státy, 97210
- Legacy Good Samaritan Hospital and Medical Center
-
Portland, Oregon, Spojené státy, 97213
- Providence Portland Medical Center
-
Portland, Oregon, Spojené státy, 97225
- Providence Saint Vincent Medical Center
-
Tualatin, Oregon, Spojené státy, 97062
- Legacy Meridian Park Hospital
-
-
Pennsylvania
-
Allentown, Pennsylvania, Spojené státy, 18103
- Lehigh Valley Hospital-Cedar Crest
-
Allentown, Pennsylvania, Spojené státy, 18104
- Saint Luke's Cancer Center - Allentown
-
Bethlehem, Pennsylvania, Spojené státy, 18017
- Lehigh Valley Hospital - Muhlenberg
-
Bethlehem, Pennsylvania, Spojené státy, 18015
- Saint Luke's University Hospital-Bethlehem Campus
-
Bryn Mawr, Pennsylvania, Spojené státy, 19010
- Bryn Mawr Hospital
-
East Stroudsburg, Pennsylvania, Spojené státy, 18301
- Pocono Medical Center
-
Easton, Pennsylvania, Spojené státy, 18045
- Saint Luke's Hospital-Anderson Campus
-
Erie, Pennsylvania, Spojené státy, 16544
- Saint Vincent Hospital
-
Hazleton, Pennsylvania, Spojené státy, 18201
- Lehigh Valley Hospital-Hazleton
-
Jefferson Hills, Pennsylvania, Spojené státy, 15025
- Jefferson Hospital
-
Media, Pennsylvania, Spojené státy, 19063
- Riddle Memorial Hospital
-
Monroeville, Pennsylvania, Spojené státy, 15146
- Forbes Hospital
-
Paoli, Pennsylvania, Spojené státy, 19301
- Paoli Memorial Hospital
-
Philadelphia, Pennsylvania, Spojené státy, 19111
- Fox Chase Cancer Center
-
Philadelphia, Pennsylvania, Spojené státy, 19107
- Thomas Jefferson University Hospital
-
Philadelphia, Pennsylvania, Spojené státy, 19107
- Pennsylvania Hospital
-
Pittsburgh, Pennsylvania, Spojené státy, 15224
- West Penn Hospital
-
Quakertown, Pennsylvania, Spojené státy, 18951
- Saint Luke's Hospital - Upper Bucks Campus
-
West Chester, Pennsylvania, Spojené státy, 19380
- Chester County Hospital
-
Wexford, Pennsylvania, Spojené státy, 15090
- Wexford Health and Wellness Pavilion
-
Willow Grove, Pennsylvania, Spojené státy, 19090
- Asplundh Cancer Pavilion
-
Wynnewood, Pennsylvania, Spojené státy, 19096
- Lankenau Medical Center
-
-
Rhode Island
-
Providence, Rhode Island, Spojené státy, 02905
- Women and Infants Hospital
-
Westerly, Rhode Island, Spojené státy, 02891
- Smilow Cancer Hospital Care Center - Westerly
-
-
South Carolina
-
Bluffton, South Carolina, Spojené státy, 29910
- Saint Joseph's/Candler - Bluffton Campus
-
Charleston, South Carolina, Spojené státy, 29425
- Medical University of South Carolina
-
-
South Dakota
-
Aberdeen, South Dakota, Spojené státy, 57401
- Avera Cancer Institute-Aberdeen
-
Rapid City, South Dakota, Spojené státy, 57701
- Rapid City Regional Hospital
-
Sioux Falls, South Dakota, Spojené státy, 57105
- Avera Cancer Institute
-
Sioux Falls, South Dakota, Spojené státy, 57117-5134
- Sanford USD Medical Center - Sioux Falls
-
Sioux Falls, South Dakota, Spojené státy, 57104
- Sanford Cancer Center Oncology Clinic
-
-
Tennessee
-
Germantown, Tennessee, Spojené státy, 38138
- The West Clinic - Wolf River
-
-
Texas
-
Austin, Texas, Spojené státy, 78712
- University of Texas at Austin
-
Austin, Texas, Spojené státy, 78701
- Dell Seton Medical Center at The University of Texas
-
Dallas, Texas, Spojené státy, 75235
- Parkland Memorial Hospital
-
Dallas, Texas, Spojené státy, 75390
- UT Southwestern/Simmons Cancer Center-Dallas
-
Fort Worth, Texas, Spojené státy, 76104
- UT Southwestern/Simmons Cancer Center-Fort Worth
-
Fort Worth, Texas, Spojené státy, 76104
- Tarrant County Hospital District/JPS Health Network
-
Houston, Texas, Spojené státy, 77030
- Houston Methodist Hospital
-
Houston, Texas, Spojené státy, 77030
- Memorial Hermann Texas Medical Center
-
Houston, Texas, Spojené státy, 77070
- Methodist Willowbrook Hospital
-
Houston, Texas, Spojené státy, 77094
- Houston Methodist West Hospital
-
Nassau Bay, Texas, Spojené státy, 77058
- Houston Methodist Saint John Hospital
-
Richardson, Texas, Spojené státy, 75080
- UT Southwestern Clinical Center at Richardson/Plano
-
Sugar Land, Texas, Spojené státy, 77479
- Houston Methodist Sugar Land Hospital
-
The Woodlands, Texas, Spojené státy, 77385
- Houston Methodist The Woodlands Hospital
-
-
Utah
-
Salt Lake City, Utah, Spojené státy, 84112
- Huntsman Cancer Institute/University of Utah
-
South Jordan, Utah, Spojené státy, 84009
- South Jordan Health Center
-
-
Virginia
-
Charlottesville, Virginia, Spojené státy, 22908
- University of Virginia Cancer Center
-
Richmond, Virginia, Spojené státy, 23235
- VCU Massey Cancer Center at Stony Point
-
Richmond, Virginia, Spojené státy, 23229
- Henrico Doctor's Hospital
-
Richmond, Virginia, Spojené státy, 23298
- VCU Massey Comprehensive Cancer Center
-
Roanoke, Virginia, Spojené státy, 24033
- Carilion Roanoke Memorial Hospital
-
-
Washington
-
Edmonds, Washington, Spojené státy, 98026
- Swedish Cancer Institute-Edmonds
-
Seattle, Washington, Spojené státy, 98122
- Swedish Medical Center-First Hill
-
Vancouver, Washington, Spojené státy, 98686
- Legacy Salmon Creek Hospital
-
-
West Virginia
-
Charleston, West Virginia, Spojené státy, 25304
- Vandalia Health/CAMC Institute for Academic Medicine
-
Morgantown, West Virginia, Spojené státy, 26506
- West Virginia University Healthcare
-
-
Wisconsin
-
Eau Claire, Wisconsin, Spojené státy, 54701
- Marshfield Medical Center-EC Cancer Center
-
Green Bay, Wisconsin, Spojené státy, 54301
- Saint Vincent Hospital Cancer Center Green Bay
-
Green Bay, Wisconsin, Spojené státy, 54303
- Saint Vincent Hospital Cancer Center at Saint Mary's
-
La Crosse, Wisconsin, Spojené státy, 54601
- Gundersen Lutheran Medical Center
-
Madison, Wisconsin, Spojené státy, 53792
- University of Wisconsin Carbone Cancer Center - University Hospital
-
Madison, Wisconsin, Spojené státy, 53718
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center
-
Marshfield, Wisconsin, Spojené státy, 54449
- Marshfield Medical Center-Marshfield
-
Milwaukee, Wisconsin, Spojené státy, 53226
- Medical College of Wisconsin
-
Minocqua, Wisconsin, Spojené státy, 54548
- Marshfield Medical Center - Minocqua
-
Mukwonago, Wisconsin, Spojené státy, 53149
- ProHealth D N Greenwald Center
-
New Richmond, Wisconsin, Spojené státy, 54017
- Cancer Center of Western Wisconsin
-
Oconomowoc, Wisconsin, Spojené státy, 53066
- ProHealth Oconomowoc Memorial Hospital
-
Oconto Falls, Wisconsin, Spojené státy, 54154
- Saint Vincent Hospital Cancer Center at Oconto Falls
-
Rice Lake, Wisconsin, Spojené státy, 54868
- Marshfield Medical Center-Rice Lake
-
Sheboygan, Wisconsin, Spojené státy, 53081
- Saint Vincent Hospital Cancer Center at Sheboygan
-
Sheboygan, Wisconsin, Spojené státy, 53081
- Sheboygan Physicians Group
-
Stevens Point, Wisconsin, Spojené státy, 54482
- Marshfield Medical Center-River Region at Stevens Point
-
Sturgeon Bay, Wisconsin, Spojené státy, 54235-1495
- Saint Vincent Hospital Cancer Center at Sturgeon Bay
-
Waukesha, Wisconsin, Spojené státy, 53188
- UW Cancer Center at ProHealth Care
-
Weston, Wisconsin, Spojené státy, 54476
- Marshfield Medical Center - Weston
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
-
Federation of Gynecology and Obstetrics (FIGO) 2009 stage IA-IVB, non-recurrent, chemotherapy (chemo)-naive, HER2-positive endometrial cancer. The following endometrial cancer types are eligible:
-
Serous
-
Other endometrial cancers (including clear cell, endometrioid, mixed epithelial, dedifferentiated/undifferentiated)
-
Carcinosarcoma
- NOTE: Endometrial cancers that are mismatch repair deficient (dMMR) by IHC are not eligible
-
-
Histologic confirmation of the original primary tumor is required. Submission of surgical pathology report (or endometrial biopsy pathology report in patients who never undergo hysterectomy) is required
-
Patients must be within 8 weeks of primary surgery (or endometrial biopsy in patients who never undergo hysterectomy) at the time of study registration
-
Patients may have measurable disease, non-measurable disease, or no measurable disease. In patients with measurable disease, lesions will be defined and monitored by RECIST v 1.1. Measurable disease is defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded). Each lesion must be >= 10 mm when measured by CT or magnetic resonance imaging (MRI). Lymph nodes must be >= 15 mm in short axis when measured by CT or MRI
-
For patients with uterine-confined (stage I) disease, the tumor must be invasive into the myometrium. Any amount of myoinvasion is acceptable for eligibility. Patients with non-invasive disease, endometrial intraepithelial carcinoma alone, or disease confined to a polyp will be excluded
-
All patients must have tumors that are HER2 positive as defined by American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) 2018 Breast Cancer guidelines. IHC and ISH testing will be done locally, at each participating institution and interpreted by local pathologists. In general HER2 positivity is defined as any of the following:
- 3+ immunohistochemistry (IHC),
- 2+ IHC with positive in situ hybridization (ISH) Alternatively, patients could be eligible if next generation sequencing (NGS) demonstrates HER2 (ERBB2) amplification. NGS testing can be performed through any designated labs as per the National Cancer Institute (NCI) MATCH/NCI Combo-MATCH trial.
Pathology report showing results of institutional HER2 testing (or NGS testing results) must be submitted.
Sites must submit all results available (IHC, ISH, and NGS)
-
Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2
-
Age >= 18
-
Platelets >= 100,000/mcl (within 14 days prior to registration)
-
Absolute neutrophil count (ANC) >= 1,500/mcl (within 14 days prior to registration)
-
Creatinine =< 1.5 x institutional/laboratory upper limit of normal (ULN) or estimated Glomerular filtration rate (eGFR) >= 50 mL/min using either the Cockcroft-Gault equation, the Modification of Diet in Renal Disease Study, or as reported in the comprehensive metabolic panel/basic metabolic panel (eGFR) (within 14 days prior to registration)
-
Total serum bilirubin level =< 1.5 x ULN (patients with known Gilbert's disease who have bilirubin level =< 3 x ULN may be enrolled) (within 14 days prior to registration)
-
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 3 x ULN (within 14 days prior to registration)
-
Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months of registration are eligible for this trial
-
Although the uterus will have been removed in the vast majority of patients, for patients of child-bearing potential: negative urine or serum pregnancy test. If the urine test is positive or cannot be confirmed as negative, a serum pregnancy test is required. Patients will be considered of non-reproductive potential if they are either:
- Postmenopausal (defined as at least 12 months with no menses without an alternative medical cause; in women < 45 years of age, a high follicle stimulating hormone [FSH] level in the postmenopausal range may be used to confirm a postmenopausal state in women not using hormonal contraception or hormonal replacement therapy. In the absence of 12 months of amenorrhea, a single FSH measurement is insufficient); OR
- Have had a hysterectomy and/or bilateral oophorectomy, bilateral salpingectomy or bilateral tubal ligation/occlusion at least 6 weeks prior to registration
- Have a congenital or acquired condition that prevents childbearing
-
Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial
-
Patients with evidence of chronic hepatitis B virus (HBV) infection must have an undetectable HBV viral load on suppressive therapy, if indicated
-
Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load
-
Patients with treated brain metastases are eligible if follow-up brain imaging after central nervous system (CNS)-directed therapy shows no evidence of progression
-
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry and, for patients treated in the United States (U.S.), authorization permitting release of personal health information
Exclusion Criteria:
-
Prior Therapy:
-
Patients must NOT have received prior chemotherapy, biologic therapy, or targeted therapy for treatment of endometrial carcinoma
-
Patients must NOT have received prior radiation therapy for treatment of endometrial carcinoma. Prior radiation includes external beam pelvic radiation therapy, external beam extended field pelvic/para-aortic radiation therapy, and/or intravaginal brachytherapy
- NOTE: Vaginal brachytherapy for treatment of endometrial cancer is permitted during study treatment. Planned use of vaginal brachytherapy must be declared at time of registration
-
Patients may have received prior hormonal therapy for treatment of endometrial carcinoma. All hormonal therapy must be discontinued at least one week prior to registration
-
-
Patients may not have a planned interval cytoreduction or hysterectomy, prior to documentation of progression, after study registration
-
Patients may not have planned external beam radiotherapy, prior to documentation of progression, after study registration
-
Significant cardiovascular disease including:
- Uncontrolled hypertension, defined as systolic > 150 mm Hg or diastolic > 90 mm Hg despite antihypertensive medications
- Myocardial infarction or unstable angina within 6 months prior to registration
- New York Heart Association functional classification II, III or IV
- Serious cardiac arrhythmia requiring medication. This does not include asymptomatic, atrial fibrillation with controlled ventricular rate
-
Significant lung disease: dyspnea at rest grade 2 or greater (resulting from extensive tumor involvement or other causes), pneumonitis grade 2 or greater, interstitial lung disease grade 2 or greater, idiopathic pulmonary fibrosis, cystic fibrosis, Aspergillosis, active tuberculosis, or history of opportunistic infections (pneumocystis pneumonia or cytomegalovirus pneumonia)
-
Patients with uncontrolled intercurrent illness including, but not limited to: ongoing or active infection (except for uncomplicated urinary tract infection), uncontrolled interstitial lung disease, symptomatic congestive heart failure, or psychiatric illness/social situations that would limit compliance with study requirements
-
Treatment with strong CYP2C8 or CYP3A4 inhibitors or inducers within 14 days or 5 drug-elimination half-lives, whichever is longer, prior to registration
-
Women who are unwilling to discontinue nursing
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Aktivní komparátor: Arm I (paclitaxel, carboplatin)
Patients receive paclitaxel IV over 3 hours and carboplatin IV over 30-60 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for 6 cycles in the absence of disease progression or unacceptable toxicity. Patients with SD or PR who still have measurable disease after completion of cycle 6 may receive 4 additional cycles of this treatment at the discretion of the treating physician. Patients undergo ECHO or MUGA and CT throughout the study. Additionally, patients may optionally undergo blood sample collection throughout the study, vaginal brachytherapy on study, and urine sample collection prior to treatment. |
Given IV
Ostatní jména:
Given IV
Ostatní jména:
Undergo CT
Ostatní jména:
Undergo ECHO
Ostatní jména:
Undergo MUGA
Ostatní jména:
Undergo blood and urine sample collection
Ostatní jména:
Undergo vaginal brachytherapy
Ostatní jména:
|
|
Experimentální: Arm II (paclitaxel, carboplatin, Herceptin Hylecta)
Patients receive paclitaxel IV over 3 hours, carboplatin IV over 30-60 minutes, and trastuzumab/hyaluronidase-oysk SC over 2-5 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for 6 cycles in the absence of disease progression or unacceptable toxicity. Patients with SD or PR who still have measurable disease after completion of cycle 6 may receive 4 additional cycles of this treatment at the discretion of the treating physician. MAINTENANCE: Patients receive trastuzumab/hyaluronidase-oysk SC over 2-5 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for up to 1 year in the absence of disease progression or unacceptable toxicity. Patients with SD or PR may continue maintenance therapy for up to 3 years from the start of treatment. Patients undergo ECHO or MUGA and CT throughout the study. Additionally patients may optionally undergo blood sample collection throughout the study, vaginal brachytherapy on study, and urine sample collection prior to treatment. |
Given IV
Ostatní jména:
Given IV
Ostatní jména:
Undergo CT
Ostatní jména:
Undergo ECHO
Ostatní jména:
Undergo MUGA
Ostatní jména:
Undergo blood and urine sample collection
Ostatní jména:
Undergo vaginal brachytherapy
Ostatní jména:
Ancillary studies Given SC
Ostatní jména:
|
|
Experimentální: Arm III (paclitaxel, carboplatin, Phesgo)
See Detailed Description. |
Given IV
Ostatní jména:
Given IV
Ostatní jména:
Undergo CT
Ostatní jména:
Undergo ECHO
Ostatní jména:
Undergo MUGA
Ostatní jména:
Undergo blood and urine sample collection
Ostatní jména:
Undergo vaginal brachytherapy
Ostatní jména:
Ancillary studies Given SC
Ostatní jména:
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Progression free survival
Časové okno: From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years from randomization
|
At the end of Phase 2 analysis, if both experimental arms demonstrate superiority to the reference, the experimental arms will be compared to each other. |
From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years from randomization
|
|
Overall survival
Časové okno: From study entry to time of death or the date of last contact, assessed up to 5 years from randomization
|
If both experimental arms demonstrate superiority to the reference arm, the experimental arms will be compared to each other. |
From study entry to time of death or the date of last contact, assessed up to 5 years from randomization
|
|
Incidence of dose limiting toxicities
Časové okno: Up to end of cycle 3 (week 12)
|
A dose limiting toxicity is any treatment-related adverse event requiring permanent discontinuation of the experimental therapy prior to the completion of treatment cycle 3. |
Up to end of cycle 3 (week 12)
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Objective response rate (ORR)
Časové okno: Within 12 months of initiating maintenance therapy
|
Defined as the binomial proportion of evaluable patients with a best overall response of complete response or partial response (by Response Evaluation Criteria in Solid Tumors 1.1) within 12 months of initiating maintenance therapy. Responses reported by the treating physician will be used for these analyses. The ORR estimates by treatment arm will be supported by their 2-sided, 95% Wilson-Score confidence intervals (Wilson, 1927; Agresti, 1998). The relative odds of response in each experimental group (versus [vs] the reference group) will be estimated using a multivariable logistic regression model specified with main effects for the treatment groups and covariate adjustments for the stratification factors reported at baseline. |
Within 12 months of initiating maintenance therapy
|
|
Duration of objective response
Časové okno: From documentation of either partial response or complete response until disease progression or death, whichever is observed first, assessed up to 5 years from randomization
|
Treatment group differences in response duration will be graphed using Kaplan-Meier methods and compared using logrank tests, stratified by the minimization factors defined at randomization. The relative hazards of progression or death in each experimental group (vs the reference group) will be estimated using a multivariable proportional hazards regression model specified with main effects for the treatment indicators and covariate adjustments for the stratification factors reported at baseline. |
From documentation of either partial response or complete response until disease progression or death, whichever is observed first, assessed up to 5 years from randomization
|
|
Incidence of adverse events (AEs)
Časové okno: Up to 5 years from randomization
|
The nature, frequency, and degree of toxicity will be tabulated at the System Organ Class and AE-specific term levels using Common Terminology Criteria version 5.0. Each patient will be represented according to the maximum grade observed for each term. Tabulations will show the number and percentage of patients by maximum grade, within the treatment group received, regardless of the randomized treatment assignment. |
Up to 5 years from randomization
|
|
HER2 expression
Časové okno: Up to 5 years from randomization
|
Correlation of HER2 immunohistochemistry expression and in situ hybridization amplification with clinical outcome and response to HER2 targeted therapies will be explored. |
Up to 5 years from randomization
|
|
Quality of life (QoL)
Časové okno: Up to 5 years from randomization
|
Measured by Functional Assessment of Cancer Therapy - Endometrial Trial Outcome Index (FACT-En TOI). |
Up to 5 years from randomization
|
Další výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
QoL deterioration
Časové okno: Baseline up to 5 years
|
The deterioration in QoL will be measured by a drop of >= 6 points in the FACT-En TOI score from baseline and lasting for more than one patient reported outcome time point in experimental and control arms. |
Baseline up to 5 years
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Vrchní vyšetřovatel: Britt K Erickson, NRG Oncology
Publikace a užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
- Urogenitální onemocnění
- Onemocnění genitálií
- Urogenitální novotvary
- Novotvary podle místa
- Ženské urogenitální onemocnění
- Ženské urogenitální onemocnění a těhotenské komplikace
- Onemocnění dělohy
- Onemocnění pohlavních orgánů, ženy
- Genitální novotvary, ženy
- Novotvary dělohy
- Novotvary
- Novotvary endometria
- Aminokyseliny, peptidy a proteiny
- Proteiny
- Organické chemikálie
- Vyšetřovací techniky
- Klinické laboratorní techniky
- Diagnostické techniky a postupy
- Diagnóza
- Uhlovodíky
- Cykloparafiny
- Uhlovodíky, alicyklické
- Uhlovodíky, cyklické
- Terpeny
- Glykosidové hydrolázy
- Hydrolázy
- Enzymy
- Enzymy a koenzymy
- Polysacharid-lyázy
- Lyázy uhlíkového kyslíku
- Lyázy
- Protilátky, monoklonální, humanizované
- Protilátky, monoklonální
- Protilátky
- Imunoglobuliny
- Imunoproteiny
- Krevní proteiny
- Sérové globuliny
- Globuliny
- Koordinační komplexy
- Taxoidy
- Cyclodecanes
- Diterpeny
- Ekonomika a organizace zdravotní péče
- Ekonomika
- Trastuzumab
- Karboplatina
- Paklitaxel
- Hyaluronoglukosaminidáza
- Manipulace se vzorkem
- pertuzumab
- Daně
Další identifikační čísla studie
- NCI-2022-01540
- U10CA180868 (Grant/smlouva NIH USA)
- NCI-2022-01540 (Identifikátor registru: CTRP (Clinical Trial Reporting Program))
- NRG-GY026 (Jiný identifikátor: CTEP)
- NRG-GY026 (Jiný identifikátor: NRG Oncology)
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .